Gregor Novak

Ljubljana, Slovenia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

High persistence and efficacy of ustekinumab as a first-line biological therapy in inflammatory bowel disease: a real-world cohort study.

High persistence and efficacy of ustekinumab as a first-line biological therapy in inflammatory bowel disease: a real-world cohort study.

Journal: Scandinavian journal of gastroenterology

Published: December 08, 2025

Applicator preferences for subcutaneous biologics in inflammatory bowel disease: influence on patient satisfaction and willingness to switch treatment.

Applicator preferences for subcutaneous biologics in inflammatory bowel disease: influence on patient satisfaction and willingness to switch treatment.

Journal: European journal of gastroenterology & hepatology

Published: August 11, 2025

First-line anti-TNF agents, ustekinumab and vedolizumab perform similarly in Crohn' disease, but not in ulcerative colitis.

First-line anti-TNF agents, ustekinumab and vedolizumab perform similarly in Crohn' disease, but not in ulcerative colitis.

Journal: European journal of gastroenterology & hepatology

Published: February 19, 2025

Directionality of endoscopic and histologic healing in ulcerative colitis: a prospective pilot study.

Directionality of endoscopic and histologic healing in ulcerative colitis: a prospective pilot study.

Journal: European journal of gastroenterology & hepatology

Published: February 07, 2025

Biological treatment approach to inflammatory bowel disease is similar in academic and nonacademic centres - prime time for decentralisation of inflammatory bowel disease care?

Biological treatment approach to inflammatory bowel disease is similar in academic and nonacademic centres - prime time for decentralisation of inflammatory bowel disease care?

Journal: European journal of gastroenterology & hepatology

Published: April 16, 2024

Remission Is Maintained after Switch from Dose-Optimised Intravenous Treatment to Subcutaneous Treatment with Vedolizumab in Inflammatory Bowel Disease.

Remission Is Maintained after Switch from Dose-Optimised Intravenous Treatment to Subcutaneous Treatment with Vedolizumab in Inflammatory Bowel Disease.

Journal: Medicina (Kaunas, Lithuania)

Published: January 08, 2024

Biopsies from ulcer edge yield higher histological activity scores than biopsies from non-ulcerated mucosa in active ulcerative colitis.

Biopsies from ulcer edge yield higher histological activity scores than biopsies from non-ulcerated mucosa in active ulcerative colitis.

Journal: European journal of gastroenterology & hepatology

Published: March 26, 2023

Ustekinumab Dosing Individualization in Crohn's Disease Guided by a Population Pharmacokinetic-Pharmacodynamic Model.

Ustekinumab Dosing Individualization in Crohn's Disease Guided by a Population Pharmacokinetic-Pharmacodynamic Model.

Journal: Pharmaceutics

Published: September 06, 2021

Ustekinumab concentrations shortly after escalation to monthly dosing may identify endoscopic remission in refractory Crohn's disease.

Ustekinumab concentrations shortly after escalation to monthly dosing may identify endoscopic remission in refractory Crohn's disease.

Journal: European journal of gastroenterology & hepatology

Published: August 17, 2021

Natural History and Risk Stratification of Recurrent Crohn's Disease After Ileocolonic Resection: A Multicenter Retrospective Cohort Study.

Natural History and Risk Stratification of Recurrent Crohn's Disease After Ileocolonic Resection: A Multicenter Retrospective Cohort Study.

Journal: Inflammatory bowel diseases

Published: December 02, 2020

Endoscopic remission can be predicted by golimumab concentrations in patients with ulcerative colitis treated with the changed label.

Endoscopic remission can be predicted by golimumab concentrations in patients with ulcerative colitis treated with the changed label.

Journal: European journal of gastroenterology & hepatology

Published: August 18, 2020

Young GI angle: International research fellowship as a way to foster clinical research at your department - our stories.

Young GI angle: International research fellowship as a way to foster clinical research at your department - our stories.

Journal: United European gastroenterology journal

Published: August 01, 2020

Showing 1-12 of 27

Last Updated: 09/26/2026